BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Johnston FM, Beckman M. Updates on Management of Gastric Cancer. Curr Oncol Rep 2019;21:67. [PMID: 31236716 DOI: 10.1007/s11912-019-0820-4] [Cited by in Crossref: 42] [Cited by in F6Publishing: 40] [Article Influence: 14.0] [Reference Citation Analysis]
Number Citing Articles
1 Wei XL, Luo TQ, Li JN, Xue ZC, Wang Y, Zhang Y, Chen YB, Peng C. Development and Validation of a Prognostic Classifier Based on Lipid Metabolism-Related Genes in Gastric Cancer. Front Mol Biosci 2021;8:691143. [PMID: 34277706 DOI: 10.3389/fmolb.2021.691143] [Reference Citation Analysis]
2 Xie S, Chang Y, Jin H, Yang F, Xu Y, Yan X, Lin A, Shu Q, Zhou T. Non-coding RNAs in gastric cancer. Cancer Lett 2020;493:55-70. [PMID: 32712234 DOI: 10.1016/j.canlet.2020.06.022] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
3 Cheng J, Sha Z, Zhang R, Ge J, Chen P, Kuang X, Chang J, Ren K, Luo X, Chen S, Gou X. L22 ribosomal protein is involved in dynamin-related protein 1-mediated gastric carcinoma progression. Bioengineered 2022;13:6650-64. [PMID: 35230214 DOI: 10.1080/21655979.2022.2045842] [Reference Citation Analysis]
4 Xia F, Sun Z, Wu JH, Zou Y. Intussusception after reconstruction following gastrectomy for gastric cancer. World J Surg Oncol 2021;19:340. [PMID: 34876149 DOI: 10.1186/s12957-021-02456-3] [Reference Citation Analysis]
5 Huang R, Shen K, He Q, Hu Y, Sun C, Guo C, Pan Y. Metabolic Profiling of Urinary Chiral Amino-Containing Biomarkers for Gastric Cancer Using a Sensitive Chiral Chlorine-Labeled Probe by HPLC-MS/MS. J Proteome Res 2021;20:3952-62. [PMID: 34229439 DOI: 10.1021/acs.jproteome.1c00267] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
6 Liu Z, Liang Y, Tang X, Qu H. Decrease in Blood Neutrophil-to-Lymphocyte Ratio Indicates Better Survival After Neoadjuvant Chemotherapy in Patients With Advanced Gastric Cancer. Front Surg 2021;8:745748. [PMID: 34869556 DOI: 10.3389/fsurg.2021.745748] [Reference Citation Analysis]
7 Yue L, Lu Y, Li Y, Wang Y. Prognostic Value of C-Reactive Protein to Albumin Ratio in Gastric Cancer: A Meta-Analysis. Nutr Cancer 2021;73:1864-71. [PMID: 32940549 DOI: 10.1080/01635581.2020.1817510] [Reference Citation Analysis]
8 Li X, Yang J, Gu X, Xu J, Li H, Qian J, Chen L. The Expression and Clinical Significance of Aldo-Keto Reductase 1 Member B1 in Gastric Carcinoma. DNA Cell Biol 2020;39:1322-7. [PMID: 32412859 DOI: 10.1089/dna.2020.5550] [Reference Citation Analysis]
9 Li Z, Liu X, Luo N, Pang Y, Hou Y, Jiang G. Long non-coding RNA CERS6-AS1 plays a prognostic role in promoting the progression of gastric cancer. Bioengineered 2021;12:12931-9. [PMID: 34852705 DOI: 10.1080/21655979.2021.2012620] [Reference Citation Analysis]
10 Wan XM, Zhou XL, Du YJ, Shen H, Yang Z, Ding Y. TASP1 Promotes Proliferation and Migration in Gastric Cancer via EMT and AKT/P-AKT Pathway. J Immunol Res 2021;2021:5521325. [PMID: 34012990 DOI: 10.1155/2021/5521325] [Reference Citation Analysis]
11 Zhou N, Wang W, Xu C, Yu W. Circular RNA PLEC acts as a sponge of microRNA-198 to promote gastric carcinoma cell resistance to paclitaxel and tumorigenesis. Pathol Res Pract 2021;224:153487. [PMID: 34225215 DOI: 10.1016/j.prp.2021.153487] [Reference Citation Analysis]
12 Cao B, Yao LH, Feng X. Tribulus saponins inhibit proliferation, migration, and invasion of gastric cancer cells by regulating Wnt3a/β-catenin signaling pathway. Shijie Huaren Xiaohua Zazhi 2022; 30(4): 191-197 [DOI: 10.11569/wcjd.v30.i4.191] [Reference Citation Analysis]
13 Zhu J, Luo C, Zhao J, Zhu X, Lin K, Bu F, Yu Z, Zou F, Zhu Z. Expression of LOX Suggests Poor Prognosis in Gastric Cancer. Front Med (Lausanne) 2021;8:718986. [PMID: 34595188 DOI: 10.3389/fmed.2021.718986] [Reference Citation Analysis]
14 Tan B, Li Y, Zhao Q, Fan L, Zhang M. The impact of Harmine hydrochloride on growth, apoptosis and migration, invasion of gastric cancer cells. Pathol Res Pract 2020;216:152995. [PMID: 32402536 DOI: 10.1016/j.prp.2020.152995] [Reference Citation Analysis]
15 Wang H, Zhang L, Luo Q, Liu J, Wang G. MORC protein family-related signature within human disease and cancer. Cell Death Dis 2021;12:1112. [PMID: 34839357 DOI: 10.1038/s41419-021-04393-1] [Reference Citation Analysis]
16 Qian H, Lv X, Song Q, Su R, Xie T, Wu D, Chang R, Chen L, Yang Y, Chen Y, Wang X, Ru Y, Shang L, Guo X. Association of dysbindin expression with individualized postoperative prognosis and chemotherapy benefit among patients with gastric adenocarcinoma. J Cancer 2021;12:6740-8. [PMID: 34659563 DOI: 10.7150/jca.60576] [Reference Citation Analysis]
17 Su Y, Huang J, Hu J. m6A RNA Methylation Regulators Contribute to Malignant Progression and Have Clinical Prognostic Impact in Gastric Cancer. Front Oncol 2019;9:1038. [PMID: 31681576 DOI: 10.3389/fonc.2019.01038] [Cited by in Crossref: 37] [Cited by in F6Publishing: 40] [Article Influence: 12.3] [Reference Citation Analysis]
18 Wu C, Lin X, Li Z, Chen Z, Xie W, Zhang X, Wang X. A Diagnostic Nomogram Based on 18F-FDG PET/CT for Bone Metastasis of Gastric Cancer. Front Cell Dev Biol 2021;9:783466. [PMID: 34970546 DOI: 10.3389/fcell.2021.783466] [Reference Citation Analysis]
19 Xu J, Yao Y, Xu B, Li Y, Su Z. Unsupervised learning of cross-modal mappings in multi-omics data for survival stratification of gastric cancer. Future Oncol 2022;18:215-30. [PMID: 34854737 DOI: 10.2217/fon-2021-1059] [Reference Citation Analysis]
20 Yu Z, Cao W, Han C, Wang Z, Qiu Y, Wang J, Wei M, Wang J, Zhang S, Liu S, Mo S, Chen J. Biomimetic Metal-Organic Framework Nanoparticles for Synergistic Combining of SDT-Chemotherapy Induce Pyroptosis in Gastric Cancer. Front Bioeng Biotechnol 2022;10:796820. [DOI: 10.3389/fbioe.2022.796820] [Reference Citation Analysis]
21 Nakamura K, Shiozaki A, Kosuga T, Shimizu H, Kudou M, Ohashi T, Arita T, Konishi H, Komatsu S, Kubota T, Fujiwara H, Okamoto K, Kishimoto M, Konishi E, Otsuji E. The expression of the alpha1 subunit of Na+/K+-ATPase is related to tumor development and clinical outcomes in gastric cancer. Gastric Cancer 2021. [PMID: 34251542 DOI: 10.1007/s10120-021-01212-6] [Reference Citation Analysis]
22 Wang Q, Gu M, Zhuang Y, Chen J. The Long Noncoding RNA MAGI1-IT1 Regulates the miR-302d-3p/IGF1 Axis to Control Gastric Cancer Cell Proliferation. Cancer Manag Res 2021;13:2959-67. [PMID: 33833579 DOI: 10.2147/CMAR.S305108] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
23 Duan X, Yu X, Li Z. Circular RNA hsa_circ_0001658 regulates apoptosis and autophagy in gastric cancer through microRNA-182/Ras-related protein Rab-10 signaling axis. Bioengineered 2022;13:2387-97. [PMID: 35030981 DOI: 10.1080/21655979.2021.2024637] [Reference Citation Analysis]
24 Gu H, Zhong Y, Liu J, Shen Q, Wei R, Zhu H, Zhang X, Xia X, Yao M, Ni M. The Role of miR-4256/HOXC8 Signaling Axis in the Gastric Cancer Progression: Evidence From lncRNA-miRNA-mRNA Network Analysis. Front Oncol 2022;11:793678. [DOI: 10.3389/fonc.2021.793678] [Reference Citation Analysis]
25 Xu Y, Feng Y, Sun Z, Li Q. RNF168 promotes RHOC degradation by ubiquitination to restrain gastric cancer progression via decreasing HDAC1 expression. Biochem Biophys Res Commun 2021;557:135-42. [PMID: 33865221 DOI: 10.1016/j.bbrc.2021.03.123] [Reference Citation Analysis]
26 Chen Y, Xiang J, Liu D, Xiao J, Xiong F, Wei K, Liu A, Chen S, Zhu Y, Meng X, Peng J. Multidisciplinary team consultation for resectable Gastric Cancer: A propensity score matching analysis. J Cancer 2021;12:1907-14. [PMID: 33753988 DOI: 10.7150/jca.53365] [Reference Citation Analysis]
27 Wu Y, Zhao H. Circ_0074027 binds to EIF4A3 and promotes gastric cancer progression. Oncol Lett 2021;22:704. [PMID: 34457059 DOI: 10.3892/ol.2021.12965] [Reference Citation Analysis]
28 Mulazzani GEG, Corti F, Della Valle S, Di Bartolomeo M. Nutritional Support Indications in Gastroesophageal Cancer Patients: From Perioperative to Palliative Systemic Therapy. A Comprehensive Review of the Last Decade. Nutrients 2021;13:2766. [PMID: 34444926 DOI: 10.3390/nu13082766] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
29 Wen X, Han W, Liu C. Long non-coding RNA TTTY15 silencing inhibits gastric cancer progression by sponging microRNA-98-5p to down-regulate cyclin D2 expression. Bioengineered 2022;13:7380-91. [PMID: 35266852 DOI: 10.1080/21655979.2022.2047398] [Reference Citation Analysis]
30 Tan R, Zhang G, Liu R, Hou J, Dong Z, Deng C, Wan S, Lai X, Cui H. Identification of Early Diagnostic and Prognostic Biomarkers via WGCNA in Stomach Adenocarcinoma. Front Oncol 2021;11:636461. [PMID: 34221961 DOI: 10.3389/fonc.2021.636461] [Reference Citation Analysis]
31 Fonseca Cabral G, Azevedo Dos Santos Pinheiro J, Vidal AF, Santos S, Ribeiro-Dos-Santos Â. piRNAs in Gastric Cancer: A New Approach Towards Translational Research. Int J Mol Sci 2020;21:E2126. [PMID: 32204558 DOI: 10.3390/ijms21062126] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 4.0] [Reference Citation Analysis]
32 Liu X, Ma X, Liu F, Liu Z, Tang X, Ji M, Zheng J, Moreira L. Gastric Cancer Screening Methods: A Comparative Study of the Chinese New Gastric Cancer Screening Score and Kyoto Classification of Gastritis. Gastroenterology Research and Practice 2022;2022:1-7. [DOI: 10.1155/2022/7639968] [Reference Citation Analysis]
33 Zhou Q, Chen Y, Pan J, Zhou L, Lin J. Application of a novel scoring system for gastric cancer opportunistic screening in hospital visits. BMC Gastroenterol 2022;22. [DOI: 10.1186/s12876-022-02315-9] [Reference Citation Analysis]
34 Yuan X, Zhao Q, Zhang Y, Xue M. The role and mechanism of HLA complex group 11 in cancer. Biomed Pharmacother 2021;143:112210. [PMID: 34563948 DOI: 10.1016/j.biopha.2021.112210] [Reference Citation Analysis]
35 Bhardwaj P, Bhandari G, Kumar Y, Gupta S. An Investigational Approach for the Prediction of Gastric Cancer Using Artificial Intelligence Techniques: A Systematic Review. Arch Computat Methods Eng. [DOI: 10.1007/s11831-022-09737-4] [Reference Citation Analysis]
36 Charalampakis N, Tsakatikas S, Schizas D, Kykalos S, Tolia M, Fioretzaki R, Papageorgiou G, Katsaros I, Abdelhakeem AAF, Sewastjanow-Silva M, Rogers JE, Ajani JA. Trimodality treatment in gastric and gastroesophageal junction cancers: Current approach and future perspectives. World J Gastrointest Oncol 2022; 14(1): 181-202 [DOI: 10.4251/wjgo.v14.i1.181] [Reference Citation Analysis]
37 He Z, Xu JG. Evaluation of the efficiency and safety of combined chemotherapy and molecular-targeted therapy in the treatment of advanced gastric cancer: A protocol for systematic review and meta-analysis. Medicine (Baltimore) 2021;100:e27557. [PMID: 34766560 DOI: 10.1097/MD.0000000000027557] [Reference Citation Analysis]
38 Jiang L, Li Y, He Y, Wei D, Yan L, Wen H. Knockdown of m6A Reader IGF2BP3 Inhibited Hypoxia-Induced Cell Migration and Angiogenesis by Regulating Hypoxia Inducible Factor-1α in Stomach Cancer. Front Oncol 2021;11:711207. [PMID: 34621671 DOI: 10.3389/fonc.2021.711207] [Reference Citation Analysis]
39 Ricci A, Gallorini M, Del Bufalo D, Cataldi A, D’agostino I, Carradori S, Zara S. Negative Modulation of the Angiogenic Cascade Induced by Allosteric Kinesin Eg5 Inhibitors in a Gastric Adenocarcinoma In Vitro Model. Molecules 2022;27:957. [DOI: 10.3390/molecules27030957] [Reference Citation Analysis]
40 Rizzo A, Mollica V, Ricci AD, Maggio I, Massucci M, Rojas Limpe FL, Fabio FD, Ardizzoni A. Third- and later-line treatment in advanced or metastatic gastric cancer: a systematic review and meta-analysis. Future Oncol 2020;16:4409-18. [PMID: 31793342 DOI: 10.2217/fon-2019-0429] [Cited by in Crossref: 22] [Cited by in F6Publishing: 22] [Article Influence: 7.3] [Reference Citation Analysis]
41 Alkhaffaf B, Metryka A, Blazeby JM, Glenny AM, Adeyeye A, Costa PM, Diez Del Val I, Gisbertz SS, Guner A, Law S, Lee HJ, Li Z, Nakada K, Reim D, Vorwald P, Baiocchi GL, Allum W, Chaudry MA, Griffiths EA, Williamson PR, Bruce IA. Core outcome set for surgical trials in gastric cancer (GASTROS study): international patient and healthcare professional consensus. Br J Surg 2021:znab192. [PMID: 34165555 DOI: 10.1093/bjs/znab192] [Reference Citation Analysis]
42 Xu Y, Xu W, Lu Z, Cheung MH, Lin M, Liang C, Lou J, Chen Y. Anti-Gastric Cancer Effect of Purified Omphalia lapidescens Protein via Regulating the JAK/STAT3 Signaling Pathway. Nutr Cancer 2021;:1-12. [PMID: 34601984 DOI: 10.1080/01635581.2021.1960385] [Reference Citation Analysis]
43 Zhang H, Pang F, Yue R. Treatment activity of 0D/2D coordination complexes on gastric carcinoma by inhibiting the cancer cell viability. Journal of the Indian Chemical Society 2022;99:100326. [DOI: 10.1016/j.jics.2021.100326] [Reference Citation Analysis]
44 Chen Y, Wu Y, Tang M. Downregulation of LINC01857 Increases Sensitivity of Gastric Carcinoma Cells to Cisplatin. Computational and Mathematical Methods in Medicine 2022;2022:1-8. [DOI: 10.1155/2022/3325686] [Reference Citation Analysis]
45 Pecoraro A, Crescenzi L, Varricchi G, Marone G, Spadaro G. Heterogeneity of Liver Disease in Common Variable Immunodeficiency Disorders. Front Immunol 2020;11:338. [PMID: 32184784 DOI: 10.3389/fimmu.2020.00338] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
46 Liu H, Dai W. Circular RNA 0000654 facilitates the growth of gastric cancer cells through absorbing microRNA-149-5p to up-regulate inhibin-beta A. Bioengineered 2022;13:469-80. [PMID: 35100076 DOI: 10.1080/21655979.2021.2009414] [Reference Citation Analysis]
47 Lin M, Yao W, Xiao Y, Dong Z, Huang W, Zhang F, Zhou X, Liang M. Resveratrol-modified mesoporous silica nanoparticle for tumor-targeted therapy of gastric cancer. Bioengineered 2021;12:6343-53. [PMID: 34506231 DOI: 10.1080/21655979.2021.1971507] [Reference Citation Analysis]
48 Cui HY, Rong JS, Chen J, Guo J, Zhu JQ, Ruan M, Zuo RR, Zhang SS, Qi JM, Zhang BH. Exosomal microRNA-588 from M2 polarized macrophages contributes to cisplatin resistance of gastric cancer cells. World J Gastroenterol 2021; 27(36): 6079-6092 [PMID: 34629821 DOI: 10.3748/wjg.v27.i36.6079] [Reference Citation Analysis]
49 Luo M, Liang C. LncRNA LINC00483 promotes gastric cancer development through regulating MAPK1 expression by sponging miR-490-3p. Biol Res 2020;53:14. [PMID: 32293550 DOI: 10.1186/s40659-020-00283-6] [Cited by in Crossref: 19] [Cited by in F6Publishing: 19] [Article Influence: 9.5] [Reference Citation Analysis]
50 Wu MD, Ye JT, Zhu BL, Ye FM, Wang WY. Effect and mechanisms of LINC00152 knockdown on chemotherapy resistance in mitomycin-resistant gastric cancer NCI-N87/MMC cells. Shijie Huaren Xiaohua Zazhi 2021; 29(7): 332-339 [DOI: 10.11569/wcjd.v29.i7.332] [Reference Citation Analysis]
51 Jiang H, Hu K, Xia Y, Liang L, Zhu X. Long Noncoding RNA KLF3-AS1 Acts as an Endogenous RNA of miR-223 to Attenuate Gastric Cancer Progression and Chemoresistance. Front Oncol 2021;11:704339. [PMID: 34745937 DOI: 10.3389/fonc.2021.704339] [Reference Citation Analysis]
52 Fan J, Jiang H, Sun L, Zhang Q, Liu H. Effect of Rhizoma alismatis on the expression of hub genes in the treatment of gastric cancer. Transl Cancer Res 2021;10:4087-95. [PMID: 35116706 DOI: 10.21037/tcr-21-1041] [Reference Citation Analysis]
53 Yang Z, Wang D, Zhang C, Liu H, Hao M, Kan S, Liu D, Liu W. The Applications of Gold Nanoparticles in the Diagnosis and Treatment of Gastrointestinal Cancer. Front Oncol 2022;11:819329. [DOI: 10.3389/fonc.2021.819329] [Reference Citation Analysis]
54 Runkel M, Verst R, Spiegelberg J, Fichtner-Feigl S, Hoeppner J, Glatz T. Perioperative FLOT chemotherapy plus surgery for oligometastatic esophagogastric adenocarcinoma: surgical outcome and overall survival. BMC Surg 2021;21:35. [PMID: 33435947 DOI: 10.1186/s12893-020-01035-9] [Reference Citation Analysis]
55 Wang Y, Zhang L, Yang Y, Lu S, Chen H. Progress of Gastric Cancer Surgery in the era of Precision Medicine. Int J Biol Sci 2021;17:1041-9. [PMID: 33867827 DOI: 10.7150/ijbs.56735] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
56 Chen YH, Li CL, Chen WJ, Liu J, Wu HT. Diverse roles of FOXO family members in gastric cancer. World J Gastrointest Oncol 2021; 13(10): 1367-1382 [PMID: 34721771 DOI: 10.4251/wjgo.v13.i10.1367] [Reference Citation Analysis]
57 Deng S, Li L, Xu S, Wang X, Han T. Promotion of gastric tumor initiating cells in a 3D collagen gel culture model via YBX1/SPP1/NF-κB signaling. Cancer Cell Int 2021;21:599. [PMID: 34758833 DOI: 10.1186/s12935-021-02307-x] [Reference Citation Analysis]
58 Huo J, Guan G, Cai J, Wu L. Integrated analysis of 1804 samples of six centers to construct and validate a robust immune-related prognostic signature associated with stromal cell abundance in tumor microenvironment for gastric cancer. World J Surg Oncol 2022;20:4. [PMID: 34983559 DOI: 10.1186/s12957-021-02485-y] [Reference Citation Analysis]
59 He C, Qi W, Wang Z. Effect and mechanism of downregulating the long-chain noncoding RNA TM4SF1-AS1 on the proliferation, apoptosis and invasion of gastric cancer cells. World J Surg Oncol 2021;19:226. [PMID: 34330293 DOI: 10.1186/s12957-021-02334-y] [Reference Citation Analysis]
60 Yang H, Tian W, Zhou B. Sarcopenia and a 5-mRNA risk module as a combined factor to predict prognosis for patients with stomach adenocarcinoma. Genomics 2021;114:361-77. [PMID: 34933074 DOI: 10.1016/j.ygeno.2021.12.011] [Reference Citation Analysis]
61 Zhang L, Li Y, Kou W, Xia Y, Yu X, Du X. Reminiscence therapy exhibits alleviation of anxiety and improvement of life quality in postoperative gastric cancer patients: A randomized, controlled study. Medicine (Baltimore) 2021;100:e26821. [PMID: 34477119 DOI: 10.1097/MD.0000000000026821] [Reference Citation Analysis]
62 Han X, Wang DZ, Yuan M, Bai WJ. Lemur tyrosine kinase 2 silencing inhibits the proliferation of gastric cancer cells by regulating GSK-3β phosphorylation and β-catenin nuclear translocation. Bioengineered 2021. [PMID: 34719320 DOI: 10.1080/21655979.2021.1999375] [Reference Citation Analysis]
63 Supruniuk K, Czarnomysy R, Muszyńska A, Radziejewska I. Combined Action of Anti-MUC1 Monoclonal Antibody and Pyrazole-Platinum(II) Complexes Reveals Higher Effectiveness towards Apoptotic Response in Comparison with Monotherapy in AGS Gastric Cancer Cells. Pharmaceutics 2021;13:968. [PMID: 34206951 DOI: 10.3390/pharmaceutics13070968] [Reference Citation Analysis]
64 Liu H, Wang H, Dong A, Huo X, Wang H, Wang J, Si J. The Inhibition of Gastric Cancer Cells’ Progression by 23,24-Dihydrocucurbitacin E through Disruption of the Ras/Raf/ERK/MMP9 Signaling Pathway. Molecules 2022;27:2697. [DOI: 10.3390/molecules27092697] [Reference Citation Analysis]
65 Zhou D, Wang L, Cui Q, Iftikhar R, Xia Y, Xu P. Repositioning Lidocaine as an Anticancer Drug: The Role Beyond Anesthesia. Front Cell Dev Biol 2020;8:565. [PMID: 32766241 DOI: 10.3389/fcell.2020.00565] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 2.5] [Reference Citation Analysis]
66 Chen Z, Xu C, Pan X, Cheng G, Liu M, Li J, Mei Y. lncRNA DSCR8 mediates miR-137/Cdc42 to regulate gastric cancer cell proliferation, invasion, and cell cycle as a competitive endogenous RNA. Mol Ther Oncolytics 2021;22:468-82. [PMID: 34553033 DOI: 10.1016/j.omto.2021.05.010] [Reference Citation Analysis]
67 Farkhondeh T, Pourbagher-Shahri AM, Azimi-Nezhad M, Forouzanfar F, Brockmueller A, Ashrafizadeh M, Talebi M, Shakibaei M, Samarghandian S. Roles of Nrf2 in Gastric Cancer: Targeting for Therapeutic Strategies. Molecules 2021;26:3157. [PMID: 34070502 DOI: 10.3390/molecules26113157] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
68 Song L, Gao M, Tan L, Ma Z, Ni P, Zhou M, Na D. Application Potential of Mg–Zn–Nd Alloy as a Gastrointestinal Anastomosis Nail Material. Acta Metall Sin (Engl Lett ) 2022;35:609-20. [DOI: 10.1007/s40195-021-01296-0] [Reference Citation Analysis]
69 Wang G, Yang L, Hu M, Hu R, Wang Y, Chen B, Jiang X, Cui R. Comprehensive Analysis of the Prognostic Significance of Hsa-miR-100-5p and Its Related Gene Signature in Stomach Adenocarcinoma. Front Cell Dev Biol 2021;9:736274. [PMID: 34604236 DOI: 10.3389/fcell.2021.736274] [Reference Citation Analysis]
70 Costantini L, Molinari R, Farinon B, Merendino N. Retinoic Acids in the Treatment of Most Lethal Solid Cancers. J Clin Med 2020;9:E360. [PMID: 32012980 DOI: 10.3390/jcm9020360] [Cited by in Crossref: 18] [Cited by in F6Publishing: 15] [Article Influence: 9.0] [Reference Citation Analysis]
71 Ji Z, Qiu Y, Cai Q, Xu C. LINC00922 acts as a novel oncogene in gastric cancer. World J Surg Onc 2022;20. [DOI: 10.1186/s12957-022-02569-3] [Reference Citation Analysis]
72 Xu C, Huang X, Lei X, Jin Z, Wu M, Liu X, Huang Y, Zhao X, Xiong Y, Sun J, Duan X, Wang J. Costunolide-Induced Apoptosis via Promoting the Reactive Oxygen Species and Inhibiting AKT/GSK3β Pathway and Activating Autophagy in Gastric Cancer. Front Cell Dev Biol 2021;9:722734. [PMID: 34869312 DOI: 10.3389/fcell.2021.722734] [Reference Citation Analysis]
73 Liang Z, Lei F, Deng J, Zhang H, Wang Y, Li J, Shi T, Yang X, Wang Z. Design, synthesis and bioactivity evaluation of novel evodiamine derivatives with excellent potency against gastric cancer. Eur J Med Chem 2021;:113960. [PMID: 34774339 DOI: 10.1016/j.ejmech.2021.113960] [Reference Citation Analysis]
74 Qiu F, Zhu Y, Shi Y, Ji J, Jin Y. Development and Verification of an Immune-Based Gene Signature for Risk Stratification and Immunotherapeutic Efficacy Assessment in Gastric Cancer. Dis Markers 2021;2021:4251763. [PMID: 34804261 DOI: 10.1155/2021/4251763] [Reference Citation Analysis]
75 Liao HY, Da CM, Liao B, Zhang HH. Roles of matrix metalloproteinase-7 (MMP-7) in cancer. Clin Biochem 2021;92:9-18. [PMID: 33713636 DOI: 10.1016/j.clinbiochem.2021.03.003] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
76 Xu HW, Jia S, Liu M, Li X, Meng X, Wu X, Yu L, Wang M, Jin CY. A low toxic CRM1 degrader: Synthesis and anti-proliferation on MGC803 and HGC27. Eur J Med Chem 2020;206:112708. [PMID: 32810752 DOI: 10.1016/j.ejmech.2020.112708] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
77 Zhang SX, Liu W, Ai B, Sun LL, Chen ZS, Lin LZ. Current Advances and Outlook in Gastric Cancer Chemoresistance: A Review. Recent Pat Anticancer Drug Discov 2021. [PMID: 34587888 DOI: 10.2174/1574892816666210929165729] [Reference Citation Analysis]
78 Zhang H, Zhang L, Lu M. Inhibition of integrin subunit alpha 11 restrains gastric cancer progression through phosphatidylinositol 3-kinase/Akt pathway. Bioengineered 2021;12:11909-21. [PMID: 34802381 DOI: 10.1080/21655979.2021.2006551] [Reference Citation Analysis]
79 Yang R, Wen J, Yang T, Dai C, Zhao Y. Evodiamine Inhibits Gastric Cancer Cell Proliferation via PTEN-Mediated EGF/PI3K Signaling Pathway. Evid Based Complement Alternat Med 2021;2021:5570831. [PMID: 34824590 DOI: 10.1155/2021/5570831] [Reference Citation Analysis]
80 Stewart JH 4th, Blazer DG 3rd, Calderon MJG, Carter TM, Eckhoff A, Al Efishat MA, Fernando DG, Foster JM, Hayes-Jordan A, Johnston FM, Lautz TB, Levine EA, Maduekwe UN, Mangieri CW, Moaven O, Mogal H, Shen P, Votanopoulos KI. The Evolving Management of Peritoneal Surface Malignancies. Curr Probl Surg 2021;58:100860. [PMID: 33832580 DOI: 10.1016/j.cpsurg.2020.100860] [Reference Citation Analysis]
81 Sun Z, Luan S, Yao Y, Qin T, Xu X, Shen Z, Yao R, Yue L. NHE1 Mediates 5-Fu Resistance in Gastric Cancer via STAT3 Signaling Pathway. Onco Targets Ther 2020;13:8521-32. [PMID: 32904684 DOI: 10.2147/OTT.S256274] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
82 Zhu J, Du S, Zhang J, Huang G, Dong L, Ren E, Liu D. microRNA-10a-5p from gastric cancer cell-derived exosomes enhances viability and migration of human umbilical vein endothelial cells by targeting zinc finger MYND-type containing 11. Bioengineered 2022;13:496-507. [PMID: 34969361 DOI: 10.1080/21655979.2021.2009962] [Reference Citation Analysis]
83 Liu J, Li Z, Yu G, Wang T, Qu G, Wang Y. LINC01232 Promotes Gastric Cancer Proliferation through Interacting with EZH2 to Inhibit the Transcription of KLF2. J Microbiol Biotechnol 2021;31:1358-65. [PMID: 34409953 DOI: 10.4014/jmb.2106.06041] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
84 Yang Y, Kang W, Yuan Y, Duan C, Chen W, Yu C, Sun Y. circ-0007707/miR-429/PDGFD Pathway Regulates the Progression of Gastric Cancer by Modulating the Immune-Gene Signature. Journal of Oncology 2022;2022:1-19. [DOI: 10.1155/2022/2214686] [Reference Citation Analysis]
85 Yu D, Li S, Silva CG. Therapeutic Effect of Cu(II) Complex with Photocatalytic Property on Gastric Cancer by Inhibiting the Proliferation of Tumor Cells. Journal of Chemistry 2022;2022:1-7. [DOI: 10.1155/2022/5349278] [Reference Citation Analysis]
86 Wu Y, Du J. Downregulated Reprimo by LINC00467 participates in the growth and metastasis of gastric cancer. Bioengineered 2022;13:11893-906. [PMID: 35549646 DOI: 10.1080/21655979.2022.2063662] [Reference Citation Analysis]
87 Sun B, Sun H, Wang Q, Wang X, Quan J, Dong D, Lun Y. Circular RNA circMAN2B2 promotes growth and migration of gastric cancer cells by down-regulation of miR-145. J Clin Lab Anal 2020;34:e23215. [PMID: 32020674 DOI: 10.1002/jcla.23215] [Cited by in Crossref: 7] [Cited by in F6Publishing: 9] [Article Influence: 3.5] [Reference Citation Analysis]
88 Jiang X, Stockwell BR, Conrad M. Ferroptosis: mechanisms, biology and role in disease. Nat Rev Mol Cell Biol 2021;22:266-82. [PMID: 33495651 DOI: 10.1038/s41580-020-00324-8] [Cited by in Crossref: 67] [Cited by in F6Publishing: 80] [Article Influence: 67.0] [Reference Citation Analysis]